K
Keranova
Instruments for ophthalmic surgery
About Keranova
Keranova specializes in ophthalmic surgery technology, focusing on enhancing cataract procedures with its proprietary Threshold Scanning System (TSS). This system utilizes Optical Coherence Tomography (OCT) to accurately detect tissue photo disruption thresholds within the lens, optimizing the planning phase of the FEMTOMATRIX cataract procedure. The TSS process involves a three-step method that efficiently delivers laser spots with varying energy levels to a specific lens area, ensuring precision and effectiveness. Keranova primarily serves ophthalmic surgeons and clinics, operating within the medical device market. The business model revolves around the development and sale of advanced surgical equipment, generating revenue through direct sales and potential licensing agreements.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Saint-Étienne, France
- Employees
- 29
- Open positions
- None listed
- Dealroom signal
- 64.4/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Ophthalmology, Surgery, Spinout, Adherent French Tech One, biotech medtech and e-health, Observatoire Deeptech, Woman Founder, observatoire industrial tech, DT and LS
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Sep 2019 | $26M | $106M | Supernova Invest · Financiere Arbevel | ↗ |
| SERIES A✓Equity / VC | Apr 2016 | $4.4M | $18M | Mérieux Equity Partners | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Keranova is 600 monthly website visits, down 37.5% over the last three months. Keranova's team declined 3.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Mérieux Equity Partners
Supernova Invest- FAFinanciere Arbevel
Other known investors5 additional known investors
CNRS Innovation
French National Centre for Scientific Research - CNRS
Jean Monnet-Saint-Etienne University
PULSALYS
University of Lyon
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Keranova on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Keranova’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.